AVITHRAPID scientists uncover how a repurposed antibiotic disrupts the core of the coronavirus replication machinery – opening new doors for broad-spectrum antiviral development. A Strategic Target: The Viral Protease 3CLpro SARS-CoV-2, the virus behind COVID-19, uses a specific enzyme, the 3C-like protease